kabutan

TERUMO CORPORATION(4543) Summary

4543
TSE Prime
TERUMO CORPORATION
2,071.5
JPY
+27.0
(+1.32%)
Mar 13, 3:30 pm JST
12.99
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
2,071
Mar 13, 10:30 pm JST
Summary Chart Historical News Financial Result
PER
22.4
PBR
2.01
Yield
1.45%
Margin Trading Ratio
1.25
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
2,039.5 JPY 12.80 USD
Previous Close Mar 12
2,044.5 JPY 12.86 USD
High Mar 13, 10:16 am
2,090.0 JPY 13.13 USD
Low Mar 13, 9:00 am
2,038.5 JPY 12.80 USD
Volume
8,709,000
Trading Value
0.02T JPY 0.11B USD
VWAP
2061.94 JPY 12.94 USD
Minimum Trading Value
207,150 JPY 1,299 USD
Market Cap
3.07T JPY 0.02T USD
Number of Trades
10,594
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
High
1-Year Average
6,881
1-Year High Apr 7, 2025
26,620
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 166,700 1,862,100 11.17
Feb 27, 2026 172,700 1,940,600 11.24
Feb 20, 2026 178,100 2,345,700 13.17
Feb 13, 2026 220,900 2,051,300 9.29
Feb 6, 2026 209,900 2,213,400 10.55
Company Profile
TERUMO CORPORATION is a leading manufacturer of medical devices, with a strong presence in the cardiovascular field. The company holds a high global market share in catheters and heart-lung machines.
Sector
Precision Instruments
TERUMO CORPORATION is a major medical device manufacturer with its business divided into three segments: "Cardiac and Vascular Company," "Medical Care Solutions Company," and "Blood and Cell Technologies Company." The group consists of numerous consolidated subsidiaries and equity-method affiliates, operating globally with an overseas sales ratio approaching 80%. The company offers a wide range of products across various business fields, with a particular strength in cardiovascular care, providing comprehensive solutions to meet the needs of medical professionals.